Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Rapid and Robust Mobilization of CD34+ HSCs without G-CSF Following Administration of Mgta-145 Alone or in Combination with Plerixafor

John F. DiPersio, MD PhD, Jonathan Hoggatt, PhD, Steven Devine, MD, Lukasz Biernat, MD, Haley Howell, BS, BA, Veit Schmelmer, PhD, Jason R. Neale, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, Kevin A. Goncalves, PhD, Glen D. Raffel, MD PhD, Patrick C. Falahee, PhD, Dwight M. Morrow, PhD, John C. Davis, Jr., MD MPH, MS

Blood (2019) 134 (Supplement_1): 1961.

https://doi.org/10.1182/blood-2019-127523

Published: 2019

Journal Articles

A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Swetha Kambhampati, MD, Bita Fakhri, MDMPH, Weiyun Ai, MD PhD, Lawrence D Kaplan, MD, Joseph Tuscano, MD, Matthew J. Wieduwilt, MD PhD, Akshay Sudhindra, MD, Jimmy Hwang, PhD, Jesika Reiner, MPH, Michelle Martinelli, Charlie Aoun, BS, Teresa Ta, Diem Le, Michelle Padilla, Erika Crawford, Charalambos Andreadis, MD

Blood (2019) 134 (Supplement_1): 2828.

https://doi.org/10.1182/blood-2019-123279

Published: 2019

Journal Articles

Donor Cell Myeloma: A Unique Case

Guillermo J. Ruiz-Argüelles, FRCP, MACP, Alejandro Ruiz-Argüelles, MD, Javier Garces-Eisele, MD, Virginia Reyes-Nuñez, PhD, Maria Fernanda Vallejo-Villalobos, PhD, Gisela B. Gomez-Cruz, MD

Blood (2018) 132 (Supplement 1): 5743.

https://doi.org/10.1182/blood-2018-99-112526

Published: 2018

Journal Articles

Leukemic-Phase Diffuse Large B-Cell Lymphoma with t(14;18), CDKN2A and MLL Deletion Presenting with an Infiltrative Skin Rash

Iris Y Sheng, MD, Diana Olguta Treaba, MD, Kenneth D. Bishop, MD PhD

Blood (2016) 128 (22): 5419.

https://doi.org/10.1182/blood.V128.22.5419.5419

Published: 2016

Journal Articles

Evaluating Causes of Back Pain in Patients with Sickle Cell Disease

Andrea R Whitfield, DO, Julie Kanter, MD

Blood (2015) 126 (23): 4593.

https://doi.org/10.1182/blood.V126.23.4593.4593

Published: 2015

Journal Articles

Report of Rare Urachal Carcinoma Presenting with Thrombocytopenia and Microangiopathic Hemolytic Anemia

Ari H. Elman, MD, Zeba Singh, MD, Heather D. Mannuel, MD MBA, Mya S. Thein, MD

Blood (2014) 124 (21): 5026.

https://doi.org/10.1182/blood.V124.21.5026.5026

Published: 2014

Journal Articles

Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside

Pinar Ataca, MD, Selami Kocak Toprak, MD, Erden Atilla, MD, Pervin Topcuoglu, MD, Meltem Kurt Yuksel, MD, Gulsah Kaygusuz, MD, Isinsu Kuzu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Osman Ilhan, MD, Nahide Konuk, MD

Blood (2014) 124 (21): 5462.

https://doi.org/10.1182/blood.V124.21.5462.5462

Published: 2014

Journal Articles

A Phase II Trial of TBL12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma

Anjali Varma Desai, MD, Meina Lu, N.P., Sara Marcus, M.P.H., Ankeeta Saran, B.A., Aditya Malankar, B.S., Amitabha Mazumder, MD

Blood (2014) 124 (21): 5733.

https://doi.org/10.1182/blood.V124.21.5733.5733

Published: 2014

Journal Articles

A rare cause of lower back pain

Denise Wolleschak, Florian H. Heidel

Blood (2014) 124 (2): 165.

https://doi.org/10.1182/blood-2014-03-565713

Published: 2014

Journal Articles

Severe Pulmonary Complication in Chemotherapy-Naive African-American Patient Following Bortezomib Therapy: a Case Report

Elizabeth G Befekadu, M.D, Khadega A Abuelgasim, MD, Anita Aggarwal, DO, PhD

Blood (2011) 118 (21): 5144.

https://doi.org/10.1182/blood.V118.21.5144.5144

Published: 2011

Journal Articles

Exploring Vertebral Height Deficits in Patients with Thalassemia and Sickle Cell Disease,

Ellen B Fung, PhD, RD, CCD, Kathryn N Reget, Drucilla Haines, PNP, Aenor Sawyer, MD, Ashutosh Lal, MD

Blood (2011) 118 (21): 3198.

https://doi.org/10.1182/blood.V118.21.3198.3198

Published: 2011

Journal Articles

Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain

Regina García, Guillermo F Sanz, MD, PhD, Dunia de Miguel Llorente, Benet Nomdedeu, MD, M Mar Romero, Teresa Bernal, Juan Besalduch, Elena Amutio, Salut Brunet, Grupo Andaluz de Smd

Blood (2010) 116 (21): 1852.

https://doi.org/10.1182/blood.V116.21.1852.1852

Published: 2010

Journal Articles

Safety and Efficacy of Intrathecal Liposome-Encapsulated Cytarabine for Central Nervous System (CNS) Prophylaxis in Adult Patients with Burkitt and Atypical Burkitt Lymphoma Treated with the R-CODOX-M/R-IVAC (Magrath) Regimen: Results of a Phase II Study.

Ferdinando Frigeri, MD, Filippo Russo, MD, Manuela Arcamone, MD, Chiara Fraira, MD, Gennaro Russo, MD, Gaetana Capobianco, MD, Cristina Becchimanzi, MD, Arturo Cuomo, MD, Gianpaolo Marcacci, MD, Gennaro Esposito, MD, Rosaria De Filippi, MD, PhD, Gaetano Corazzelli, MD, Umberto Vitolo, MD, Antonio Pinto, MD

Blood (2009) 114 (22): 3716.

https://doi.org/10.1182/blood.V114.22.3716.3716

Published: 2009

Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma.

Manish Sharma, MD, Peter Thall, PhD, Xuemei Wang, PhD, Chitra Hosing, MD, Floralyn L Mendoza, MD, Eric Han, MD, Michael Wang, MD, Donna Weber, MD, Jatin Shah, MD, Amin Alousi, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa F Khouri, MD, Uday Popat, MD, Marcos de Lima, MD, Richard E Champlin, MD, Sergio Giralt, MD, Muzaffar Qazilbash, MD

Blood (2009) 114 (22): 2309.

https://doi.org/10.1182/blood.V114.22.2309.2309

Published: 2009

Journal Articles

POEMS Syndrome Objective Clinical Response of Polyneuropathy to Lenolidomide.

Reetika Grewal, MD, Said Beydoun, MD, Ann Mohrbacher, MD

Blood (2009) 114 (22): 4964.

https://doi.org/10.1182/blood.V114.22.4964.4964

Published: 2009

Journal Articles

Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms.

Steven Grant, MD, Daniel Sullivan, David Roodman, MD, PhD, Robert K Stuart, MD, Edward Perkins, Sarah Kolla, Viswanathan Ramakrishnan, John Wright, MD, PhD, Alexander Dimitri Colevas, M B Tombes, John D Roberts

Blood (2008) 112 (11): 1573.

https://doi.org/10.1182/blood.V112.11.1573.1573

Published: 2008

Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, M.D., Chitra M Hosing, Floralyn L Mendoza, Eric Han, Michael Wang, MD, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei, Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, MD, PhD, Richard E. Champlin, Sergio A. Giralt

Blood (2008) 112 (11): 3320.

https://doi.org/10.1182/blood.V112.11.3320.3320

Published: 2008

Journal Articles

Systemic Mastocytosis with c-KIT D816V Mutation Treated with Dasatinib.

Rudolf Benz, MD, Juerg Boesiger, Md, Jorg Fehr, Md

Blood (2007) 110 (11): 4656.

https://doi.org/10.1182/blood.V110.11.4656.4656

Published: 2007

Journal Articles

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Daisuke Wakao, MD, PhD, Toshiya Suzuki, MD, PhD, Katsuro Ito, MD, PhD, Katsuhiko Yoshida, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2005) 106 (11): 4720.

https://doi.org/10.1182/blood.V106.11.4720.4720

Published: 2005

Journal Articles

Ehrlichiosis Mimicking T-Cell Lymphoma/Leukemia.

Ashok Malani, MD, FRCS, Robert Weigand, MD, Vicram Gupta, MD, Lawrence Hertzberg, MD, Gautam Rangineni, MD

Blood (2005) 106 (11): 4343.

https://doi.org/10.1182/blood.V106.11.4343.4343

Published: 2005

NARROW

Rapid and Robust Mobilization of CD34+ HSCs without G-CSF Following Administration of Mgta-145 Alone or in Combination with Plerixafor

A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Donor Cell Myeloma: A Unique Case

Leukemic-Phase Diffuse Large B-Cell Lymphoma with t(14;18), CDKN2A and MLL Deletion Presenting with an Infiltrative Skin Rash

Evaluating Causes of Back Pain in Patients with Sickle Cell Disease

Report of Rare Urachal Carcinoma Presenting with Thrombocytopenia and Microangiopathic Hemolytic Anemia

Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside

A Phase II Trial of TBL12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma

A rare cause of lower back pain

Severe Pulmonary Complication in Chemotherapy-Naive African-American Patient Following Bortezomib Therapy: a Case Report

Exploring Vertebral Height Deficits in Patients with Thalassemia and Sickle Cell Disease,

Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain

Safety and Efficacy of Intrathecal Liposome-Encapsulated Cytarabine for Central Nervous System (CNS) Prophylaxis in Adult Patients with Burkitt and Atypical Burkitt Lymphoma Treated with the R-CODOX-M/R-IVAC (Magrath) Regimen: Results of a Phase II Study.

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma.

POEMS Syndrome Objective Clinical Response of Polyneuropathy to Lenolidomide.

Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms.

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Systemic Mastocytosis with c-KIT D816V Mutation Treated with Dasatinib.

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Ehrlichiosis Mimicking T-Cell Lymphoma/Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only